Insider · CIK 0001965232
Bonne J. Adams
Files at TCON (Tracon Pharmaceuticals, Inc.). First filing -, latest -.
In brief
Bonne J. Adams files SEC Form 4 as COO at TCON (Tracon Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Bonne J. Adams has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 1, 2023 | TCON Tracon Pharmaceuticals, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +99,000 | $0.00 | $0 | 99,000 | Feb 9, 2023 |
Questions about Bonne J. Adams
Answered from the filings on this page, as of the latest one.
Is Bonne J. Adams buying or selling?
Bonne J. Adams has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Bonne J. Adams's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bonne J. Adams has 0.
Where does Bonne J. Adams file Form 4?
Bonne J. Adams has filed Form 4 at TCON (Tracon Pharmaceuticals, Inc.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.